Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria

NCT02876549 is registered in ClinicalTrials.gov with University of Oxford as lead sponsor.

NCT NCT02876549
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02876549 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
G6PD Assessment Before Primaquine for Radical Treatment of Vivax Malaria
Lead sponsor
University of Oxford
Phase
Phase 4
Overall status
Completed
Start date
September 1, 2016
Completion date
November 30, 2018
Enrollment
1,000 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

vivax malaria